Hôpital de la Pitié-Salpétrière
Paris, 75013, France
NCT Number: NCT02055261
The appearance of postural instability and gait disorders is a major turning point in the evolution of Parkinson's disease (PD). These axial symptoms are usually unresponsive to L-Dopa and represent a severe impairment for the patients due to frequent falls and reduced outside mobility. There is no effective pharmacological treatment available for these symptoms, and their pathophysiology is not well known : it is currently assumed that non-dopaminergic brainstem lesions participate to axial symptoms in PD. Surgically, these patients cannot benefit from high frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) since this operation tends to even aggravate axial symptoms unresponsive to L-Dopa in some patients. A dysfunction of the pedunculopontine nucleus (PPN) might be at the origin of these axial symptoms, since the PPN participates in the maintenance of posture and motion in primates. In PD patients, recent reports have suggested that low frequency stimulation of the PPN may equally improve gait and posture. However, these results are debatable due to methodological limitations, insufficient clinical evaluation and uncertain anatomical targeting. Thus, our aim is to propose a low frequency PPN stimulation to six advanced PD patients according to the usual criteria for STN DBS who are, however, unsuitable for this operation due to gait and posture disorders. We will perform a randomized, double-blind and cross over design (two months periods with and without DBS randomly assigned to each patient). The targeting will be allowed by a a three-dimensional and deformable atlas of the basal ganglia fusioned with the stereotaxic magnetic resonance imaging (MRI) of each patient. Evaluations will comprise 1 month before surgery and in "Off" and "On" stimulation condition:
* clinical motor assessment in both "Off" and "On" drug state, including cardinal parkinsonian signs, gait and balance * gait initiation physiological evaluation * cognitive and behavioral testing If our hypothesis is confirmed, low frequency PPN stimulation may well represent a substantial improvement of our therapeutic options for advanced PD patients suffering from debilitating gait and posture disorders unresponsive to L-Dopa.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 1 / Phase 2
Paris, 75013, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 months and 6 months after surgery
The primary outcome criteria will be the comparison between RSGE total score in obtained 'Off' and 'On' stimulation conditions either at 4 or 6 months after surgery according to the randomized order of the cross-over
Time frame: 1 month before surgery, 1-2-3-4-5-6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 4 and 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Time frame: 1 month before surgery and 4 or 6 months after surgery
Pitié-Salpêtrière Hospital
Other
Effects of Low Frequency Deep Brain Stimulation of the Pedunculopontine Nucleus on Gait and Balance Disorders of Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03648905
Autonomic Failure, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01621581
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05699460
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Irvine, California, United States
View Trial DetailsNCT07720869
Basal Ganglia Diseases, Brain Diseases
Baton Rouge, Louisiana, United States
View Trial Details